Literature DB >> 19181630

Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model.

David K Meyerholz1, Michelle A Griffin, Elaine M Castilow, Steven M Varga.   

Abstract

A comparative study of histochemical detection of eosinophils in fixed murine tissue is lacking. Five histochemical methods previously reported for eosinophil detection were quantitatively and qualitatively compared in an established murine RSV vaccine-enhanced inflammation model. Nonspecific neutrophil staining was evaluated in tissue sections of neutrophilic soft tissue lesions and bone marrow from respective animals. Eosinophils had granular red to orange-red cytoplasmic staining, depending on the method, whereas neutrophils had, when stained, a more homogenous cytoplasmic pattern. Nonspecific background staining of similar coloration was variably seen in vascular walls and erythrocytes. Astra Blue/Vital New Red, Congo Red, Luna, Modified Hematoxylin and Eosin, and Sirius Red techniques were all effective in detecting increased eosinophil recruitment compared to controls; however, differences in eosinophil quantification varied significantly between techniques. Astra Blue/Vital New Red had the best specificity for differentiating eosinophils and neutrophils but had a reduced ability to enumerate eosinophils and was the most time intensive. The Luna stain had excessive nonspecific staining of tissues and a reduced enumeration of infiltrating eosinophils, which made it suboptimal. For multiple parameters such as eosinophil detection, specificity, and contrast with background tissues, the Sirius Red followed by Congo Red and Modified Hematoxylin and Eosin methods were useful, each with their own staining qualities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181630      PMCID: PMC2664312          DOI: 10.1177/0192623308329342

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  24 in total

1.  Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease.

Authors:  Marjan Daneshpouy; Gerard Socie; Marc Lemann; Jacqueline Rivet; Eliane Gluckman; Anne Janin
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

Review 2.  Asthma, inflammation, eosinophils and bronchial hyperresponsiveness.

Authors:  H Smith
Journal:  Clin Exp Allergy       Date:  1992-02       Impact factor: 5.018

3.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.

Authors:  H W Kim; J G Canchola; C D Brandt; G Pyles; R M Chanock; K Jensen; R H Parrott
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

4.  An improved Sirius red method for amyloid.

Authors:  B D Llewellyn
Journal:  J Med Lab Technol       Date:  1970-07

5.  Interleukin 5 release into asthmatic airways 4 and 24 hours after endobronchial allergen challenge: its relationship with eosinophil recruitment.

Authors:  L M Teran; M P Carroll; J K Shute; S T Holgate
Journal:  Cytokine       Date:  1999-07       Impact factor: 3.861

6.  Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection.

Authors:  D S Friend; M F Gurish; K F Austen; J Hunt; R L Stevens
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

7.  Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma.

Authors:  Karim Y Vermaelen; Didier Cataldo; Kurt Tournoy; Tania Maes; An Dhulst; Renaud Louis; Jean-Michel Foidart; Agnès Noël; Romain Pauwels
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

Review 8.  Eosinophilic interstitial lung disease.

Authors:  W Michael Alberts
Journal:  Curr Opin Pulm Med       Date:  2004-09       Impact factor: 3.155

9.  Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.

Authors:  V A Fulginiti; J J Eller; O F Sieber; J W Joyner; M Minamitani; G Meiklejohn
Journal:  Am J Epidemiol       Date:  1969-04       Impact factor: 4.897

10.  Effects of residual oil fly ash (ROFA) in mice with chronic allergic pulmonary inflammation.

Authors:  Fernanda M Arantes-Costa; Fernanda D T Q S Lopes; Alessandra C Toledo; Pedro A Magliarelli-Filho; Henrique T Moriya; Regiane Carvalho-Oliveira; Thais Mauad; Paulo H N Saldiva; Milton A Martins
Journal:  Toxicol Pathol       Date:  2008-05-13       Impact factor: 1.902

View more
  56 in total

1.  A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.

Authors:  Meagan Bolles; Damon Deming; Kristin Long; Sudhakar Agnihothram; Alan Whitmore; Martin Ferris; William Funkhouser; Lisa Gralinski; Allison Totura; Mark Heise; Ralph S Baric
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  ATP binding cassette transporter G1 deletion induces IL-17-dependent dysregulation of pulmonary adaptive immunity.

Authors:  David W Draper; Kymberly M Gowdy; Jennifer H Madenspacher; Rhonda H Wilson; Gregory S Whitehead; Hideki Nakano; Arun R Pandiri; Julie F Foley; Alan T Remaley; Donald N Cook; Michael B Fessler
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

3.  Allergic airway inflammation decreases lung bacterial burden following acute Klebsiella pneumoniae infection in a neutrophil- and CCL8-dependent manner.

Authors:  Daniel E Dulek; Dawn C Newcomb; Kasia Goleniewska; Jaqueline Cephus; Weisong Zhou; Sara Reiss; Shinji Toki; Fei Ye; Rinat Zaynagetdinov; Taylor P Sherrill; Timothy S Blackwell; Martin L Moore; Kelli L Boyd; Jay K Kolls; R Stokes Peebles
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

4.  The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants.

Authors:  Youri Lee; Eun-Ju Ko; Ki-Hye Kim; Young-Tae Lee; Hye Suk Hwang; Yu-Jin Jung; Subbiah Jeeva; Young-Man Kwon; Baik Lin Seong; Sang Moo Kang
Journal:  Antiviral Res       Date:  2019-05-28       Impact factor: 5.970

5.  Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma.

Authors:  Shailendra R Singh; Nikol Sullo; Maria Matteis; Giuseppe Spaziano; John McDonald; Ruth Saunders; Lucy Woodman; Konrad Urbanek; Antonella De Angelis; Raffaele De Palma; Rachid Berair; Mitesh Pancholi; Vijay Mistry; Francesco Rossi; Remo Guerrini; Girolamo Calò; Bruno D'Agostino; Christopher E Brightling; David G Lambert
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

6.  Obesity shifts house dust mite-induced airway cellular infiltration from eosinophils to macrophages: effects of glucocorticoid treatment.

Authors:  J Diaz; L Warren; L Helfner; X Xue; P K Chatterjee; M Gupta; M H Solanki; M Esposito; V Bonagura; C N Metz
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

7.  Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry.

Authors:  Kimberly D Dyer; Katia E Garcia-Crespo; Kristin E Killoran; Helene F Rosenberg
Journal:  J Immunol Methods       Date:  2011-04-30       Impact factor: 2.303

8.  Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase.

Authors:  Stephen D Zucker; Megan E Vogel; Tammy L Kindel; Darcey L H Smith; Gila Idelman; Uri Avissar; Ganesh Kakarlapudi; Michelle E Masnovi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-17       Impact factor: 4.052

9.  Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles.

Authors:  Young-Man Kwon; Youri Lee; Ki Hye Kim; Yu Jin Jung; Zhuo Li; Subbiah Jeeva; Sujin Lee; Martin L Moore; Sang-Moo Kang
Journal:  Vaccine       Date:  2019-09-18       Impact factor: 3.641

10.  Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles.

Authors:  Youri Lee; Young-Tae Lee; Eun-Ju Ko; Ki-Hye Kim; Hye Suk Hwang; Soojin Park; Young-Man Kwon; Sang Moo Kang
Journal:  Hum Vaccin Immunother       Date:  2017-11-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.